Literature DB >> 7287444

Thyroid function after radiotherapy and laryngectomy for carcinoma of the larynx.

B V Palmer, N Gaggar, H J Shaw.   

Abstract

Total levels of thyroxine (T4) and thyroid-stimulating hormone (TSH) were measured in 37 patients who had previously had carcinoma of the larynx treated by radiotherapy and total laryngectomy with thyroid lobectomy. Ten percent of the patients had clinical features of hypothyroidism and 30% had total T4 levels below the lower limit of normal. A further 40% had results in the low normal range. Forty-four percent of patients had raised TSH levels, 90% of these having low or low normal T4 levels. The histology of the thyroid gland was normal in all 37 patients. Attention should be given to preserving intact the vasculature of the contralateral thyroid lobe whenever it is necessary to remove the ipsilateral thyroid lobe during a laryngectomy. Proper postoperative assessment of thyroid gland function is desirable in all these patients to identify those at risk of hypothyroidism and to avoid unnecessary morbidity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7287444     DOI: 10.1002/hed.2890040105

Source DB:  PubMed          Journal:  Head Neck Surg        ISSN: 0148-6403


  3 in total

Review 1.  Current concepts of surveillance and its significance in head and neck cancer.

Authors:  Kapila Manikantan; Raghav C Dwivedi; Suhail I Sayed; K A Pathak; Rehan Kazi
Journal:  Ann R Coll Surg Engl       Date:  2011-11       Impact factor: 1.891

2.  Predictors of thyroid gland involvement in hypopharyngeal squamous cell carcinoma.

Authors:  Jae Won Chang; Yoon Woo Koh; Woong Youn Chung; Soon Won Hong; Eun Chang Choi
Journal:  Yonsei Med J       Date:  2015-05       Impact factor: 2.759

3.  The incidence of thyroid gland invasion in advanced laryngeal squamous cell carcinoma.

Authors:  Hadi A Al-Hakami; Mohammed A Al Garni; Haya AlSubayea; Yazeed AlOtaibi; A Neazy; W Jameel; Mohammed Albouq; A Alnufaie; Nawaf Fatani
Journal:  Braz J Otorhinolaryngol       Date:  2019-12-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.